Business is accelerating at the perfect moment.

Cetera Investment Advisers trimmed its position in Axcelis Technologies, Inc. (NASDAQ: ACLS) by 48.5% during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 5,127 shares of the semiconductor company's stock after selling 4,828 shares during the period. Cetera Investment Advisers' holdings in Axcelis Technologies were

On August 18, 2026, Axcelis Technologies Inc (ACLS) shares fell 5.9%, bringing the current price to $135.36. Over the past year, the stock has seen a high of $1

California State Teachers Retirement System boosted its holdings in shares of Axcelis Technologies, Inc. (NASDAQ: ACLS) by 21.3% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 36,420 shares of the semiconductor company's stock after buying an additional 6,390 shares during the period.

Axcelis Technologies, Inc. (ACLS) Q2 2026 Earnings Call Transcript

Axcelis Technologies (ACLS) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of $0.9 per share. This compares to earnings of $1.13 per share a year ago.

Axcelis Technologies NASDAQ: ACLS reported second-quarter 2026 revenue of $215 million and non-GAAP diluted earnings per share of $1.06, with both figures exceeding management's expectations. The company raised its outlook for the full year, now expecting mid-single-digit revenue growth after previously forecasting revenue roughly flat with 2025.

Q2 2026 Highlights: Revenue of $215.2 million GAAP Gross Margin of 42.4%, and Non-GAAP Gross Margin of 42.7% GAAP Operating Margin of 9.4% and Non-GAAP Operating Margin of 14.7% GAAP Diluted Earnings Per Share of $0.75, and Non-GAAP Diluted Earnings Per Share of $1.06 BEVERLY, Mass., Aug. 6, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the second quarter ended June 30, 2026.

BEVERLY, Mass., July 29, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced the company's plans to participate in the following upcoming investor conferences in August:  The KBCM Technology Leadership Forum on Monday, August 10th at the Montage Deer Valley, Park City, UT.

System qualified for emerging PMIC device application requiring advanced 15 MeV implant capability BEVERLY, Mass., July 28, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today the successful Purion XEmax™ high energy implanter evaluation closure at a leading foundry.